GlobalData Archives - Express Pharma

Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030

M&A in pharma sees deals worth $14.8 bn in Nov 2024

Diagnosed prevalent cases of type 1 diabetes across 7MM set to reach 3.166 million in 2033

Pharma dose CMOs face growth slowdown, but opportunities lie ahead

Digital transformation can accelerate drug development and discovery process

Biologic therapies show progress in severe asthma treatment and remission potential

Paratek Phase IIb data shows omadacycline’s potential to address unmet needs in NTM treatment, says GlobalData

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Diagnosed prevalent cases of primary open-angle glaucoma to reach 10 mn in 7MM by 2033

Bladder cancer diagnosed incident cases across 8MM to reach 0.34 mn in 2033